Table 2.
Clinical studies with hypomethylating agents in IPSS lower-risk MDS patients
N indicates number of patients; ORR, overall response rate; TID, 3 times/d; and SC, subcutaneous.
Clinical studies with hypomethylating agents in IPSS lower-risk MDS patients
N indicates number of patients; ORR, overall response rate; TID, 3 times/d; and SC, subcutaneous.
